The CareStart ™ COVID-19 Antigen Test is a lateral circulation immunochromatographic assay for the detection of drawn out nucleocapsid protein antigens particular to SARS-CoV-2 in nasopharyngial swab specimens straight gathered from symptomatic people who are presumed of COVID-19 by their doctor.
Functions:
Recognize intense infection in symptomatic clients with 88.4% favorable percent contract and 100% unfavorable percent contract.
Lateral circulation assay
Quick lead to 10 minutes
Nasopharyngeal swab specimen collection
Planned at POC setting (i.e., inpatient care settings) by physician running under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
Discover SARS-CoV-2 nucleocapsid protein antigen
Designated as a CLIA waived tests
Package Consists Of:
20 Test gadgets
20 Assay bugger
20 Extraction vials and caps
20 Specimen collection swabs
1 Favorable and 1 unfavorable control swabs
1 Guideline for usage
Discover more at https://hardydiagnostics.com/coronavirus-covid-19- upgrade/
http://covid19globalcases.com/carestart-covid-19-antigen-test-package/
Comments
Post a Comment